MedTrace Logo

Measuring Iron Bioavailability From Oral Iron Supplements in Healthy Pre-menopausal Women Using Stable Isotopes

NCT07563686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2026-05-04

No results posted yet for this study

Summary

In this study the investigators will compare iron absorption from 3 doses of iron (5, 10, 15 mg, given as either Spatone™ or ferrous sulphate). Our primary objective is to determine iron absorption from each preparation by measuring stable isotope (57Fe) incorporation into haemoglobin.

Conditions

  • Iron Deficiency Anaemia Due to Dietary Causes

Interventions

DIETARY_SUPPLEMENT

5mg Spatone

5mg Spatone

DIETARY_SUPPLEMENT

10mg Spatone

10mg Spatone

DIETARY_SUPPLEMENT

15mg Spatone

15mg Spatone

DIETARY_SUPPLEMENT

5mg ferrous sulphate

5mg ferrous sulphate

DIETARY_SUPPLEMENT

10mg ferrous sulphate

10 mg ferrous sulphate

DIETARY_SUPPLEMENT

15mg ferrous sulphate

15mg ferrous sulphate

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-13
Primary Completion
2025-03-31
Completion
2026-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07563686 on ClinicalTrials.gov